The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar DisordersIsabella Pacchiarotti, Shigenobu Kanba, Robert L. Findling et al.|American Journal of Psychiatry|2013Cited by 754
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser <i>v.</i> mood stabiliser aloneMauricio Tohen, Joseph R. Calabrese, Trisha Suppes et al.|The British Journal of Psychiatry|2004Cited by 328
12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive DisorderPaul Grant, Susan E. Swedo, Lisa Joseph et al.|Neuropsychopharmacology|2013Cited by 78
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysisGustavo C. Medeiros, Fernando S. Goes, Todd D. Gould et al.|Molecular Psychiatry|2022Cited by 71
Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteersJennifer W. Evans, Carlos A. Zarate|Scientific Reports|2024Cited by 9